Condition
Round Cell Liposarcoma
Total Trials
4
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
1 of 0 completed with results
Key Signals
1 with results0
Data Visualizations
Phase Distribution
4Total
Early P 1 (2)
P 1 (1)
P 2 (1)
Trial Status
Recruiting2
Withdrawn1
Terminated1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07261657Early Phase 1Recruiting
N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy
NCT06843967Phase 1Recruiting
A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma
NCT03397186Phase 2Withdrawn
Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma
NCT01957709Early Phase 1Terminated
Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma
Showing all 4 trials